🇺🇸 chlorobutanol, hexetidine in United States

15 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 15

Most-reported reactions

1. Bone Marrow Failure — 6 reports (40%)
2. Acute Generalised Exanthematous Pustulosis — 1 report (6.67%)
3. Acute Pulmonary Oedema — 1 report (6.67%)
4. Anuria — 1 report (6.67%)
5. Asthenia — 1 report (6.67%)
6. Blood Creatinine Increased — 1 report (6.67%)
7. Cardiac Flutter — 1 report (6.67%)
8. Chest Pain — 1 report (6.67%)
9. Coronary Artery Disease — 1 report (6.67%)
10. Dermatitis Exfoliative — 1 report (6.67%)

Source database →

Frequently asked questions

Is chlorobutanol, hexetidine approved in United States?

chlorobutanol, hexetidine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for chlorobutanol, hexetidine in United States?

Federico II University is the originator. The local marketing authorisation holder may differ — check the official source linked above.